WALTHAM, Mass.--(BUSINESS WIRE)--OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a clinical-stage biotechnology company developing novel therapeutics to treat cancer and eye diseases, will announce its first quarter 2007 results on Wednesday, April 25, 2007 prior to the opening of the NASDAQ Stock Market, followed by a conference call at 10:00 a.m. ET. OXiGENE’s President and Chief Executive Officer, Dr. Richard Chin, Chief Scientific Officer, Dr. David Chaplin, Chief Medical Officer, Dr. Peter Harris, Chief Business Officer, John Kollins and James Murphy, Chief Financial Officer, will host the call.
